Skip to main content

Reliance Retail-Future Group deal: Here are the key takeaways

 The deal is good news for lenders of Future Group who will now have secured outstanding loans protected as well as the retail ecosystem comprising small businesses and suppliers.

  


Reliance Industries Limited (RIL) on August 29 said it would buy retail and wholesale business, as well as the logistics and warehousing business of the Future Group, for Rs 24,713 crore.  The acquisition is being done as part of the scheme in which Future Group is merging certain companies carrying on the above-mentioned businesses into  Future Enterprises Limited (FEL).

Here are the key takeaways from the deal: 



1.    This deal cements the position of Reliance Retail as the undisputed leader in the organised retail segment and adds muscle to the ongoing battle with Amazon for the Indian e-commerce market.

 

2. The deal is good news for lenders of Future Group who will now have secured outstanding loans protected as well as the retail ecosystem comprising small businesses and suppliers.

3. Reliance Retail, which was already the largest retailer in India by a long shot, gets even larger and bigger. Its network gets a big push in the cities, where 40 percent of Future stores are present. 

4. The deal will help RIL’s retail business to expand its offline retail presence and get it ready to tap into Operator-to-Operator (O2O) as well as Business-to-Business (B2B) opportunities.


5. The Future Group houses leading retail formats, including supermarket chain Big Bazaar, upmarket food stores Foodhall, and bargain clothing chain Brand Factory. This gives them an edge into all these areas of business.

6. Biyani’s exit from a business he had painstakingly built over three decades was forced by a rising pile of debt and the searing pain wrought by the COVID-19 pandemic. This deal prevented the collapse of a vast retail group that would have otherwise been dragged through India’s bankruptcy court.

 

Comments

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...

Indigo Paints trades at over 55% premium in grey market after IPO price announcement

The grey market premium has increased significantly from Rs 400-500 on January 11 to Rs 840-850 on January 15. Indigo Paints, one of the fastest-growing paint companies in India, was trading at more than 50 percent premium over its higher issue price band of Rs 1,490 per share in the grey market after the announcement of IPO details. The premium in the grey market as of January 15 was at around Rs 840-850 per share, which means the grey market trading price stood at Rs 2,340-2,330 against the issue price of Rs 1,490, as per the data available on IPO Watch. The premium increased significantly from Rs 400-500 on January 11 to Rs 840-850 today. The grey market is an unofficial trading platform where shares get traded well before the allotment in an initial public offering and till the shares get listed on bourses. It generally estimates the expected listing price of a stock. "Currently Asian paints and Berger paints are trading at a PE of 111 and 148, respectively, while Indigo Paint...